4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000899243-21-026340
Options or other derivatives
- Director acquired 13,755,415 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Jerel Davis Director | 2021-02-16 | Grant or award · Series A Preferred Stock | +10,000,000 | $1.00 | $10,000,000 | 30,019,945 | I |
| Jerel Davis Director | 2021-03-11 | Grant or award · Series B Preferred Stock | +3,715,415 | $5.06 | $18,800,000 | 3,715,415 | I |
| Jerel Davis Director | 2021-06-24 | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | D | ||
Loading xslF345X03/doc4.xml…